Hamish Baillie Purchases 3,000 Shares of The Biotech Growth Trust PLC (LON:BIOG) Stock

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie acquired 3,000 shares of The Biotech Growth Trust stock in a transaction that occurred on Wednesday, November 27th. The stock was bought at an average price of GBX 931 ($11.86) per share, for a total transaction of £27,930 ($35,575.09).

The Biotech Growth Trust Trading Down 0.5 %

Shares of BIOG stock opened at GBX 965 ($12.29) on Friday. The company has a 50-day moving average of GBX 1,002.92 and a two-hundred day moving average of GBX 999.98. The firm has a market cap of £310.05 million, a PE ratio of 465.22 and a beta of 0.50. The Biotech Growth Trust PLC has a 1-year low of GBX 741 ($9.44) and a 1-year high of GBX 1,068.36 ($13.61). The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00.

About The Biotech Growth Trust

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.